The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates rising
Open accessAbstract
Lung cancer rates have peaked among men in many areas of the world, but rates among women continue to rise. Most lung cancers are squamous cell carcinoma, small cell carcinoma, or adenocarcinoma; trends vary according to type. We compiled population‐based morphology‐specific incidence data from registries contributing to the International Agency for Research on Cancer (IARC) databases. Unspecified cancers and carcinomas were reallocated based on a registry, time period, sex and age group‐specific basis. Where available, data from several registries within a country were pooled for analysis. Rates per 100,000 person‐years for 1980–1982 to 1995–1997 were age‐adjusted by the direct method using the world standard. Squamous cell carcinoma rates among males declined 30% or more in North America and some European countries while changing less dramatically in other areas; small cell carcinoma rates decreased less rapidly. Squamous and small cell carcinoma rates among females generally rose, with the increases especially pronounced in the Netherlands and Norway. In contrast, adenocarcinoma rates rose among males and females in virtually all areas, with the increases among males exceeding 50% in many areas of Europe; among females, rates also rose rapidly and more than doubled in Norway, Italy and France. Rates of all lung cancer types among women and adenocarcinoma among men continue to rise despite declining cigarette use in many Western countries and shifts to filtered/low‐tar cigarettes. Renewed efforts toward cessation and prevention are mandatory to curb the prevalence of cigarette smoking and to reduce lung cancer rates eventually. © 2005 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
International Statistical Classification of Diseases and Related Health Problems
(2011) · Encyclopedia of Clinical Neuropsychology · doi:10.1007/978-0-387-79948-3_3055 · Cited by 4,151
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Cancer burden in the year 2000. The global picture
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00267-2 · Cited by 2,169
Self-citationInternational Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,676
Cancer Epidemiology and Prevention
Breslow, L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550210090050 · Cited by 1,424
Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis
Khuder, S. A. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00181-1 · Cited by 522
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00739-6 · Cited by 479
Self-citationHoffmann, D., Djordjevic, M. V., & Hoffmann, I. (1997) · Preventive Medicine · doi:10.1006/pmed.1997.0183 · Cited by 421
Cited by
Lu, T., Yang, X., Huang, Y., Zhao, M., Li, M., Ma, K., Yin, J., Zhan, C., & Wang, Q. (2019) · Cancer Management and Research · doi:10.2147/cmar.s187317 · Cited by 561
Pesch, B., Kendzia, B., Gustavsson, P., Jöckel, K., Johnen, G., Pohlabeln, H., Olsson, A., Ahrens, W., Gross, I. M., Brüske, I., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27339 · Cited by 509
Global variations in lung cancer incidence by histological subtype in 2020: a population-based study
Zhang, Y., Vaccarella, S., Morgan, E., Li, M., Etxeberria, J., Chokunonga, E., Manraj, S. S., Kamate, B., Omonisi, A., & Bray, F. (2023) · The Lancet Oncology · doi:10.1016/s1470-2045(23)00444-8 · Cited by 445
Self-citationIt's all about sex: gender, lung development and lung disease
Carey, M. A., Card, J. W., Voltz, J. W., Arbes, S. J., Germolec, D. R., Korach, K. S., & Zeldin, D. C. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.08.003 · Cited by 417
Nitadori, J.-I., Bograd, A. J., Kadota, K., Sima, C. S., Rizk, N. P., Morales, E. A., Rusch, V. W., Travis, W. D., & Adusumilli, P. S. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt166 · Cited by 323
Refining the treatment of NSCLC according to histological and molecular subtypes
Thomas, A., Liu, S. V., Subramaniam, D. S., & Giaccone, G. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.90 · Cited by 321
Xu, Z., Gao, Y., Hao, Y., Li, E., Wang, Y., Zhang, J., Wang, W., Gao, Z., & Wang, Q. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.045 · Cited by 295
Current Diagnosis and Management of Small-Cell Lung Cancer
Wang, S., Zimmermann, S., Parikh, K., Mansfield, A. S., & Adjei, A. A. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.01.034 · Cited by 282
Hashibe, M., Morgenstern, H., Cui, Y., Tashkin, D. P., Zhang, Z.-F., Cozen, W., Mack, T. M., & Greenland, S. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0330 · Cited by 256
Hung, J.-J., Yeh, Y.-C., Jeng, W.-J., Wu, K.-J., Huang, B.-S., Wu, Y.-C., Chou, T.-Y., & Hsu, W.-H. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.1049 · Cited by 256
Lung cancer incidence in young women vs . young men: A systematic analysis in 40 countries
Fidler‐Benaoudia, M. M., Torre, L. A., Bray, F., Ferlay, J., & Jemal, A. (2020) · International Journal of Cancer · doi:10.1002/ijc.32809 · Cited by 248
Self-citation
Metadata
- Authors
- Devesa, S. S., Bray, F., Vizcaino, A. P., & Parkin, D. M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2005-08-16
- Volume
- 117
- Issue
- 2
- Pages
- 294-299
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2046317081
- Cited by
- 745
- References
- 29
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.